These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Osteoporosis: From Molecular Mechanisms to Therapies. Tang CH Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979046 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological agents and natural compounds: available treatments for osteoporosis. Martiniakova M; Babikova M; Omelka R J Physiol Pharmacol; 2020 Jun; 71(3):. PubMed ID: 32991310 [TBL] [Abstract][Full Text] [Related]
10. Osteoblast as a target of anti-osteoporotic treatment. Corrado A; Sanpaolo ER; Di Bello S; Cantatore FP Postgrad Med; 2017 Nov; 129(8):858-865. PubMed ID: 28770650 [TBL] [Abstract][Full Text] [Related]
11. Abaloparatide and the Spine: A Narrative Review. Thompson JC; Wanderman N; Anderson PA; Freedman BA Clin Interv Aging; 2020; 15():1023-1033. PubMed ID: 32636617 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms of anabolic therapies for osteoporosis. Canalis E; Giustina A; Bilezikian JP N Engl J Med; 2007 Aug; 357(9):905-16. PubMed ID: 17761594 [No Abstract] [Full Text] [Related]
14. [Bone remodeling: new therapeutic approaches]. Ferrari S Rev Med Suisse; 2009 Jun; 5(207):1325-8. PubMed ID: 19626933 [TBL] [Abstract][Full Text] [Related]
15. The future of osteoporosis treatment - a research update. Lippuner K Swiss Med Wkly; 2012; 142():w13624. PubMed ID: 22815185 [TBL] [Abstract][Full Text] [Related]
16. Appropriate models for novel osteoporosis drug discovery and future perspectives. Gennari L; Rotatori S; Bianciardi S; Gonnelli S; Nuti R; Merlotti D Expert Opin Drug Discov; 2015; 10(11):1201-16. PubMed ID: 26292627 [TBL] [Abstract][Full Text] [Related]
18. Osteoporosis: Mechanism, Molecular Target and Current Status on Drug Development. Li H; Xiao Z; Quarles LD; Li W Curr Med Chem; 2021; 28(8):1489-1507. PubMed ID: 32223730 [TBL] [Abstract][Full Text] [Related]
19. Anabolic agents and bone quality. Sibai T; Morgan EF; Einhorn TA Clin Orthop Relat Res; 2011 Aug; 469(8):2215-24. PubMed ID: 21132409 [TBL] [Abstract][Full Text] [Related]
20. [Therapeutic innovation in osteoporosis (antisclerostin antibody and denosumab)]. Quemerais-Durieu MA; Kerlan V; Chabre O Ann Endocrinol (Paris); 2011 Oct; 72 Suppl 1():S15-22. PubMed ID: 22008272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]